Tumor regions with high albumin extravasation showed greater pathway inhibition than regions with low albumin uptake when BRAFi was applied [P = 0.0003, two-way analysis of variance (ANOVA) interaction term describing combined effects of treatment and albumin levels on ERK-KTR activity; Fig. 7, E and F]. Here, ALB is linked to neoplasm.